LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Unique Software Platform to Improve Medical Pathology Education and Collaboration

By LabMedica International staff writers
Posted on 26 May 2014
Print article
Image: Efficient sharing of high-quality images with \"VENTANA Vector\" software for dynamic pathology training and collaboration (Photo courtesy of Ventana Medical Systems).
Image: Efficient sharing of high-quality images with \"VENTANA Vector\" software for dynamic pathology training and collaboration (Photo courtesy of Ventana Medical Systems).
A new software platform provides a flexible digital pathology solution for more efficient and effective medical training courses and sharing of high-quality images.

Ventana Medical Systems, Inc. (Ventana; Tucson, AZ, USA), member of the Roche Group (Basel, Switzerland), has now released "VENTANA Vector," a new software platform for pathology training and collaboration. The platform provides pathologists and educators with tools to build interactive training, from course development to student evaluation, and to quickly and easily share scanned images with colleagues around the globe. The software is available anywhere, anytime, and is supported on a range of tablets and mobile devices.

This innovative software enhances the learning experience, engagement, and collaboration for students while providing efficiencies for educators. Whole slide imaging has gained tremendous acceptance within pathology education because of its many advantages over traditional teaching methods. Courses that use glass slides face several potential challenges such as slide breakage, periodic re-cutting, limited availability, and the inherent quality inconsistency of multiple slide sets. "Digital pathology is gaining widespread adoption for medical education and training. The release of VENTANA Vector software expands our Digital Pathology portfolio to address the growing needs of the pathology education market. The software will make pathology training more accurate and cost-effective, while empowering students with collaborative learning strategies," said Vikram Mohan, international business leader, Digital Pathology, Ventana.

Many medical schools are relying less and less on the light microscope as the primary teaching tool in pathology. VENTANA Vector software can help standardize training content by enabling students to view high quality, consistent slide images, and eliminate the frustration of having to share limited resources such as slide sets and multi-head microscopes. "Now we can pick the best slides, scan them, and use the same digital slide set for all students. They can all access the same teaching materials anytime from their computer, tablet, or smart phone," said Dr. Sung, professor of Pathology, Women & Infants Hospital (Providence, RI, USA).

The VENTANA Vector software platform is unique in the digital pathology market in offering a highly customizable interface, ability for users to view on mobile devices with both Cloud and local hosting options, and is fully compatible with iScan Coreo and VENTANA iScan HT slide scanners.

Related Links:

Ventana Medical Systems


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.